Pharmacologically effective plasma concentrations of ranitidine.
作者信息
Peden N R, Richards D A, Saunders J H, Wormsley K G
出版信息
Lancet. 1979 Jul 28;2(8135):199-200. doi: 10.1016/s0140-6736(79)91466-1.
PMID:89310
Abstract
摘要
相似文献
1
Pharmacologically effective plasma concentrations of ranitidine.雷尼替丁的药理有效血浆浓度。
Lancet. 1979 Jul 28;2(8135):199-200. doi: 10.1016/s0140-6736(79)91466-1.
2
[Ranitidine, a newly developed histamine H2-receptor antagonist. First experimental and clinical results].雷尼替丁，一种新开发的组胺H2受体拮抗剂。首次实验和临床结果
Dtsch Med Wochenschr. 1980 Dec 12;105(50):1753-5. doi: 10.1055/s-2008-1070951.
3
[Newly developed H2-receptor antagonists in the treatment of peptic ulcer disease].[新开发的H2受体拮抗剂在消化性溃疡疾病治疗中的应用]
Wien Med Wochenschr. 1982 May 31;132(10):223-8.
4
Ranitidine and cimetidine for duodenal ulcer.雷尼替丁和西咪替丁用于治疗十二指肠溃疡。
Scand J Gastroenterol Suppl. 1981 Jun;69:115-7.
5
Controlled trial with ranitidine in the treatment of peptic ulcer.雷尼替丁治疗消化性溃疡的对照试验。
Neth J Med. 1981;24(6):224-8.
6
Duodenal ulcer: an update.十二指肠溃疡：最新进展
Mt Sinai J Med. 1981 Sep-Oct;48(5):391-6.
7
Cimetidine and ranitidine in duodenal ulcer.西咪替丁和雷尼替丁治疗十二指肠溃疡
Br Med J. 1980 Aug 16;281(6238):473-4. doi: 10.1136/bmj.281.6238.473.
8
[Therapy of duodenal ulcer with H2-blockers. 2 x 150 mg ranitidine versus 2 x 400 mg cimetidine].[H2受体阻滞剂治疗十二指肠溃疡。雷尼替丁2×150毫克与西咪替丁2×400毫克的对比]
Fortschr Med. 1983 Jan 27;101(4):139-41.
9
New drugs. H2 receptor antagonists--cimetidine and ranitidine.新药。H2受体拮抗剂——西咪替丁和雷尼替丁。
Br Med J (Clin Res Ed). 1983 Feb 26;286(6366):695-7. doi: 10.1136/bmj.286.6366.695.
10
Ranitidine in acute upper gastrointestinal haemorrhage.雷尼替丁治疗急性上消化道出血
Br Med J (Clin Res Ed). 1982 Nov 27;285(6354):1575-6. doi: 10.1136/bmj.285.6354.1575-b.
引用本文的文献
1
Clinical pharmacokinetics of ranitidine.雷尼替丁的临床药代动力学。
Clin Pharmacokinet. 1984 May-Jun;9(3):211-21. doi: 10.2165/00003088-198409030-00003.
2
The pharmacokinetics of ranitidine in patients with chronic duodenal ulceration: a comparison of responders and non-responders.雷尼替丁在慢性十二指肠溃疡患者中的药代动力学：反应者与无反应者的比较。
Eur J Clin Pharmacol. 1983;24(4):441-7. doi: 10.1007/BF00609883.
3
Mitogen stimulation of peripheral blood lymphocytes of duodenal ulcer patients during treatment with cimetidine or ranitidine.十二指肠溃疡患者在使用西咪替丁或雷尼替丁治疗期间外周血淋巴细胞的丝裂原刺激。
Gut. 1982 May;23(5):398-403. doi: 10.1136/gut.23.5.398.
4
Plasma ranitidine concentrations after intravenous administration in normal volunteers and haemodialysis patients.正常志愿者和血液透析患者静脉给药后血浆雷尼替丁浓度。
Postgrad Med J. 1983 Jan;59(687):25-7. doi: 10.1136/pgmj.59.687.25.
5
Effects of eight weeks' continuous treatment with oral ranitidine and cimetidine on gastric acid secretion, pepsin secretion, and fasting serum gastrin.口服雷尼替丁和西咪替丁连续治疗八周对胃酸分泌、胃蛋白酶分泌及空腹血清胃泌素的影响。
Gut. 1983 Jan;24(1):61-6. doi: 10.1136/gut.24.1.61.
6
Ranitidine: a review of its pharmacology and therapeutic use in peptic ulcer disease and other allied diseases.雷尼替丁：其药理学及在消化性溃疡疾病和其他相关疾病中的治疗应用综述
Drugs. 1982 Oct;24(4):267-303. doi: 10.2165/00003495-198224040-00002.
7
Ranitidine: single dose pharmacokinetics and absolute bioavailability in man.雷尼替丁：人体单剂量药代动力学及绝对生物利用度
Br J Clin Pharmacol. 1982 Aug;14(2):195-200. doi: 10.1111/j.1365-2125.1982.tb01961.x.
8
Ranitidine upon meal-induced gastric secretion: oral pharmacokinetics and plasma concentration effect relationships.雷尼替丁对进餐引起的胃酸分泌的影响：口服药代动力学及血浆浓度效应关系
Br J Clin Pharmacol. 1982 Aug;14(2):187-93. doi: 10.1111/j.1365-2125.1982.tb01960.x.
9
Pharmacokinetics of the H2- receptor antagonist ranitidine in man.H2受体拮抗剂雷尼替丁在人体中的药代动力学。
Br J Clin Pharmacol. 1981 Sep;12(3):411-5. doi: 10.1111/j.1365-2125.1981.tb01236.x.
10
Comparison of the effects of ranitidine, cimetidine and placebo on the 24 hour intragastric acidity and nocturnal acid secretion in patients with duodenal ulcer.雷尼替丁、西咪替丁和安慰剂对十二指肠溃疡患者24小时胃内酸度及夜间胃酸分泌影响的比较。
Gut. 1981 Jan;22(1):49-54. doi: 10.1136/gut.22.1.49.
Zotero 插件